Results 211 to 220 of about 121,509 (248)

THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells

Cancer Cell, 2020
Yang Xu, Li-Chung Tsao, Peishun Shou
exaly  

Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-cell Malignancies

Cell Transplantation, 2021
Yongxian Hu, Guoqing Wei, Wenjun Wu
exaly  

Chimeric antigen receptor

2015
PULÉ MARTIN, ANDERSON JOHN, THOMAS SIMON   +2 more
openaire   +12 more sources

Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase

Molecular Therapy, 2017
Crystal Mackall, Robbie Majzner, Terry Fry   +2 more
exaly  

Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma

Molecular Therapy, 2018
Hua Jiang, Zonghai Li, Xiuqi Wu
exaly  

Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy

OncoImmunology, 2020
Anja Feldmann, Claudia Arndt, Liliana Rodrigues Loureiro   +2 more
exaly  

CHIMERIC ANTIGEN RECEPTOR

2017
ONUOHA SHIMOBI, PULÉ MARTIN, THOMAS SIMON, CORDOBA SHAUN, KOKALAKI EVANGELIA   +4 more
  +8 more sources

Combining the best of two worlds: highly flexible chimeric antigen receptor adaptor molecules (CAR-adaptors) for the recruitment of chimeric antigen receptor T cells

MAbs, 2019
Christian Klein, Christian Jost, Sebastian Kobold   +2 more
exaly  

Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers

Molecular Therapy, 2019
Bruce Levine, Gregory Beatty, Michael Soulen   +2 more
exaly  

Chimeric antigen receptors

2014
ABBOT STEWART, LIANG BITAO, LI TIANJIAN
openaire   +10 more sources